Trivant Custom Portfolio Group’s Sanofi SNY Stock Holding History

Trivant Custom Portfolio Group’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$770K	Buy	15,990 +358	+2%	+$16.7K	0.42%	61
2025 Q4	$758K	Sell	15,632 -1,420	-8%	-$70.4K	0.44%	62
2025 Q3	$805K	Sell	17,052 -1,402	-8%	-$67.7K	0.41%	65
2025 Q2	$892K	Buy	18,454 +774	+4%	+$39.5K	0.49%	62
2025 Q1	$981K	Buy	17,680 +5,693	+47%	+$308K	0.56%	54
2024 Q4	$578K	Sell	11,987 -288	-2%	-$14.6K	0.34%	58
2024 Q3	$707K	Buy	12,275 +169	+1%	+$9.12K	0.41%	55
2024 Q2	$587K	Sell	12,106 -16,353	-57%	-$789K	0.36%	50
2024 Q1	$1.38M	Buy	28,459 +1,360	+5%	+$66.4K	0.88%	40
2023 Q4	$1.35M	Sell	27,099 -1,701	-6%	-$83.2K	0.9%	38
2023 Q3	$1.54M	Sell	28,800 -405	-1%	-$21.6K	1.14%	37
2023 Q2	$1.57M	Buy	+29,205	New	+$1.57M	1.11%	38

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Trivant Custom Portfolio Group's SNY Position: Q1 2026 in Review

Trivant Custom Portfolio Group increased its Sanofi (SNY) stake by 2.3% in Q1 2026, buying an estimated $16.7K and bringing the position to 15,990 shares worth $770K. The position accounts for 0.42% of the portfolio, ranked #61.

Trivant Custom Portfolio Group first reported a position in SNY in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.57M in Q2 2023. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Trivant Custom Portfolio Group held 15,990 shares of Sanofi worth $770K as of Q1 2026.
Trivant Custom Portfolio Group bought 358 Sanofi shares in Q1 2026, an estimated $16.7K.
Sanofi made up 0.42% of Trivant Custom Portfolio Group's portfolio in Q1 2026, its #61 holding.
Trivant Custom Portfolio Group first reported a position in Sanofi in Q2 2023 and has held it in 12 quarters since.
Trivant Custom Portfolio Group's Sanofi position peaked at $1.57M in Q2 2023.
738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Trivant Custom Portfolio Group's 13F filing for Q1 2026, filed 14 May 2026.